Amrita School of Medicine
150 MBBS seats · Established 2023
19 PG · 0 super-speciality course listings
Employees State Insurance Corporation Medical College, Faridabad is listed in the NMC MBBS register under government management in Haryana, with an intake of 150 seats. The register gives 2015 as its year of inception.
Listed address: Med. Supdt., ESI Hospital NH-3, ESIC Building, NIIT Faridabad- 121001 (Haryana) Faridabad
NMC institution record · Institution website listed by NMC
Recognized when degree granted on or after December,2019, 25 seats under EWS quota was permitted for 2020-21 vide latter date 09/10/2020. Annual renewal permission granted for 125 MBBS seats for AY 2024-25. LOP granted for increase in intake of 25 MBBS Seats (from 125 to 150) for the Academic Year 2025-26. Annual Renewal Permitted for 125 MBBS seats for AY 2025-26. Annual Renewal granted for 150 MBBS Seats for the AY 2026-27
23 MD/MS/diploma and 6 DM/MCh listings have a positive seat count in this snapshot. These are programme records, not an inspection of functioning departments or a promise of admission eligibility.
| Course | Type | Listed seats | Record updated |
|---|---|---|---|
D.M. CardiologyPermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | DM | 2 | 2026-09-23 |
D.M. Critical Care MedicinePermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | DM | 3 | 2026-09-23 |
M.B.B.S.Permission remarksRecognized when degree granted on or after December,2019, 25 seats under EWS quota was permitted for 2020-21 vide latter date 09/10/2020. Annual renewal permission granted for 125 MBBS seats for AY 2024-25. LOP granted for increase in intake of 25 MBBS Seats (from 125 to 150) for the Academic Year 2025-26. Annual Renewal Permitted for 125 MBBS seats for AY 2025-26. Annual Renewal granted for 150 MBBS Seats for the AY 2026-27 | M.B.B.S. | 150 | 2026-09-30 |
M.Ch. NeurosurgeryPermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | M.Ch. | 2 | 2026-09-23 |
M.Ch. Paediatric SurgeryPermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | M.Ch. | 2 | 2026-09-23 |
M.Ch. Plastic and Reconstructive Surgery/ Plastic SurgeryPermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | M.Ch. | 3 | 2026-09-23 |
M.Ch. UrologyPermission remarksNo remarks supplied. | M.Ch. | 1 | 2026-06-20 |
M.D. AnaesthesiologyPermission remarks3 Seats Approved in Academic Year 2021-22. Three(3) to Seven (7) seats have been increased u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 7 | 2026-09-23 |
M.D. AnatomyPermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 3 | 2026-09-23 |
M.D. BiochemistryPermission remarks4 Seats Approved in Academic Year 2021-22 | MD | 4 | 2026-09-23 |
M.D. Community Medicine/Social & Preventive MedicinePermission remarks3 Seats Approved in Academic Year 2021-22 | MD | 3 | 2026-09-23 |
M.D. Dermatology, Venereology and Leprosy/DermatologyPermission remarks1 Seats Approved in Academic Year 2021-22 | MD | 1 | 2026-09-23 |
M.D. Emergency MedicinePermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. LOP dated 22.06.2023 of starting 04 seats | MD | 4 | 2026-09-23 |
M.D. Forensic Medicine and Toxicology/Forensic MedicinePermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 2 | 2026-09-23 |
M.D. General MedicinePermission remarks4 Seats Approved in Academic Year 2021-22. Four(4) to Eight (8) seats have been increased u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 8 | 2026-09-23 |
M.D. Immuno Haematology and Blood Transfusion/Transfusion MedicinePermission remarks2 Seats Approved in Academic Year 2021-22 | MD | 2 | 2026-09-23 |
M.D. MicrobiologyPermission remarks3 Seats Approved in Academic Year 2021-22 | MD | 3 | 2026-09-23 |
M.D. PaediatricsPermission remarks3 Seats Approved in Academic Year 2021-22 Three(3) to Five (5) seats have been increased u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 5 | 2026-09-23 |
M.D. PathologyPermission remarks3 Seats Approved in Academic Year 2021-22 | MD | 3 | 2026-09-23 |
M.D. PharmacologyPermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 3 | 2026-09-23 |
M.D. Physical Medicine and RehabilitationPermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 3 | 2026-09-23 |
M.D. PhysiologyPermission remarksPermitted u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 3 | 2026-09-23 |
M.D. PsychiatryPermission remarks2 Seats Approved in Academic Year 2021-22 | MD | 2 | 2026-09-23 |
M.D. Radio-diagnosis /RadiologyPermission remarks3 Seats Approved in Academic Year 2021-22. Three(3) to Five(5) seats have been increased u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MD | 5 | 2026-09-23 |
M.D. Respiratory Medicine/Tuberculosis & Respiratory DiseasesPermission remarks2 Seats Approved in Academic Year 2021-22 | MD | 2 | 2026-09-23 |
M.S. General SurgeryPermission remarks4 Seats Approved in Academic Year 2021-22. Four(4) to Eight(8) seats have been increased u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MS | 8 | 2026-09-23 |
M.S. Obstetrics and GynaecologyPermission remarks4 Seats Approved in Academic Year 2021-22. Four(4) to Eight(8) seats have been increased u/s 26(1) (a) (b), 28 (1) (2) and 61 (2) during 2023-2024. | MS | 8 | 2026-09-24 |
M.S. OphthalmologyPermission remarks3 Seats Approved in Academic Year 2021-22 | MS | 3 | 2026-09-23 |
M.S. OrthopaedicsPermission remarks2 Seats Approved in Academic Year 2021-22 | MS | 2 | 2026-09-23 |
M.S. Otorhinolaryngology/ENTPermission remarks3 Seats Approved in Academic Year 2021-22 | MS | 3 | 2026-09-23 |
Source: NMC college and course search. Check course-specific eligibility and admissions routes; not all institutions or programmes use NEET PG / NEET SS.
Ranges use the allotted category, quota and round in the MCC final results. They are not the candidate’s category or a forecast. Round 2 includes new Round 2 allotments only, excluding retained Round 1 seats shown in the earlier-round columns.
No institution-matched MCC 2025 Round 1/2 data is published for this college in this snapshot. This does not mean the college had no allotments. State quota results and other rounds require separate verification.
Sources: MCC 2025 Round 1 final result · Round 2 final result · MCC archive. No state-quota, later-round or PG/SS rank data is included. Allotments do not prove joining.
Facilities have not yet been verified from a current institution-specific source. NMC listing alone does not confirm hostel availability, working equipment, bed occupancy or student access.
No public-review summary has been verified for this institution yet. Panarogya has not assigned a star rating or inferred student satisfaction. Ask current students from your intended programme and batch before deciding.
150 MBBS seats · Established 2023
19 PG · 0 super-speciality course listings
150 MBBS seats · Established 2026
0 PG · 0 super-speciality course listings
120 MBBS seats · Established 2012
7 PG · 0 super-speciality course listings